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Background: Irisin, a recently discovered myokine, is assumed to be secreted by muscle cells in response to
exercise and is involved in the regulation of energy metabolism by browning white adipose tissue cells. However,
due to the fact that previous studies revealed conflicting results concerning the association between irisin and
exercise, the aim of the present study was to investigate the potential relationship between irisin and exercise
capacity in a population-based setting.
Methods: From the population-based Study of Health in Pomerania (SHIP-TREND) 334 men and 406 women with
irisin measurements were selected and a standardised symptom limited cardiopulmonary exercise test was used.
Exercise capacity was quantified by oxygen uptake at anaerobic threshold (VO2@AT), peak exercise (peakVO2) and
maximum power output at peak exertion. In addition, the oxygen pulse was assessed. ANOVA and multivariable
linear regression analyses were performed stratified by sex and adjusted for age, weight, height and smoking.
Results: In men, we observed inverse associations between irisin serum concentration and exercise capacity
assessed by peakVO2 and maximum power output. In contrast, in women a trend towards a positive relationship
between irisin and peakVO2 was detected, whereas none of the other parameters showed significant associations
with irisin.
Conclusion: Based on a large population sample, our results did not confirm the previous reported positive linkage
between exercise and irisin. Thus the relationship needs further investigation in particular with respect to sex
differences.
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Myokines have an important role in the human body, es-
pecially in coordinating the different organs and tissues
such as the adipose tissue, liver, pancreas, bones, brain
and muscle tissue; also influencing human homoeostasis
[1-3]. In 2012, Boström et al. [4] discovered a new* Correspondence: nele.friedrich@uni-greifswald.de
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unless otherwise stated.myokine called irisin, which is secreted by muscle tissue
and is transcribed from the FNDC5 (fibronectin type III
domain-containing protein 5) gene. Irisin is assumed to
affect white adipose tissue cells by browning them, as
well as increasing energy expenditure. Furthermore, iri-
sin seems to promote increased oxygen consumption
and energy supply [5]. These effects suggest that irisin
might be the source of a potential therapeutic approach
to treating obesity and diabetes mellitus, two major dis-
eases in industrialized countries [6-11].
According to Norheim et al. [12] irisin was first known
as a peroxisome proliferator-activated receptor γ co-al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ing effects in murine adipocytes. In 2013, researchers
[12] found a positive correlation with human muscle
cells among 26 diabetic and non-diabetic subjects aged
40–65 years. The study was able to show an increase in
mRNA for PGC1 α and FNDC5 after 12 weeks of phys-
ical training in both control and pre-diabetes human
subjects. Furthermore, long-term training led to an over-
all reduction in circulating irisin levels whereas an in-
crease in irisin were only found after acute exercise. A
similar trend was shown among 12 subjects undergoing
treadmill exercise [13]. A temporary increase in irisin
levels during the first hour of exercise was revealed,
whereas after 90 minutes of exercise irisin levels were no
longer elevated. In contrast to these studies, several in-
vestigations [14-17] failed to confirm these findings.
One study published by Hecksteden et al. [17] based on
an experiment including 102 participants aged 30–60
years exposed to aerobic endurance training and strength
endurance training. This study and three others [14-16]
did not confirm an exercise related increase in irisin
levels.
However, as Hofmann et al. [8] and Novelle et al. [10]
have already stated, the results on “the regulation of Irisin
by different types of exercise are partly conflicting and
effects were only shown in highly selective patient popula-
tions so far” and therefore “it is still necessary to deepen
in several aspects in order to clarify its full potential as a
meaningful drug target in human disease states”.
Therefore the aim of the present study is to investigate
the association of irisin serum concentration with exer-
cise capacity in a subsample of the Study of Health in
Pomerania Trend (SHIP-TREND).
Methods
SHIP-TREND is a population-based study in Northeast
Germany including the cities of Greifswald, Stralsund,
Anklam and 29 surrounding communities [18]. A represen-
tative sample of 8016 adults aged 20 to 79 years was ran-
domly selected from population registries into 24 age- and
sex-specific strata. In total 4420 subjects participated in the
baseline examination of SHIP-TREND between September
2008 and September 2012. The study follows the recom-
mendations of the Declaration of Helsinki and was ap-
proved by the ethics committee of the University of
Greifswald. All participants gave written informed consent.
Measurements of irisin levels were available for a sub-
sample of 1000 subjects. Of these, 260 subjects were ex-
cluded due to the presence of at least one of the
following conditions: no participation in cardiopulmo-
nary exercise testing (CPET), pulmonary function testing
performed later than 100 days after core examination,
estimated glomerular filtration rate <30 mL/min/1.73 m2
as well as conditions related to cardiovascular diseasesincluding pacemaker, aortic or mitral valve stenosis, in-
take of digitalis glycosides [anatomical therapeutic
chemical (ATC) code C01AA] or selective calcium chan-
nel blockers with direct cardiac effects (ATC code
C08D). Those with missing values for confounding fac-
tors were also excluded. The final study population thus
comprised 740 individuals (334 men, 406 women).
Measurements
Information on age, gender, socio-demographic character-
istics and medical histories were obtained by computer-
aided personal interviews. Smoking status and physical
activity were assessed by self-report. Individuals who
participated in physical training during summer or winter
for at least one hour a week were classified as being phys-
ically active. Waist circumference (WC) was measured to
the nearest 0.1 cm using an inelastic tape midway between
the lower rib margin and the iliac crest in the horizontal
plane, with the subject standing comfortably with weight
distributed evenly on both feet. The measurement was
taken at the level of the narrowest part of the waist. All
anthropometric measurements were taken in accordance
with World Health Organization standards.
During the core examination of all participants, fasting
blood samples were drawn from the cubital vein in the
supine position and serum aliquots were prepared for
immediate analysis and for storage at −80°C. Irisin levels
were measured by a competitive enzyme-linked immuno-
sorbent assay (Adipogen AG, Liestal, Switzerland) with a
limit of detection of 0.001 μg/ml. During the course of the
study the coefficient of variation was 11.57%.
Exercise testing and gas exchange variables
A symptom-limited exercise test using a calibrated elec-
tromagnetically braked cycle ergometer with an elec-
trical seat height adjustment (Ergoselect 100, Ergoline,
Germany) was performed according to a modified Jones
protocol (stepwise increase in work load of 16 Watts/mi-
nute, starting with unloaded cycling plus the ergometer
related permanent load) [19]. Gas exchange and ventila-
tory variables were analysed breath by breath averaged
over 10-second intervals using a computer-based system;
study details are given elsewhere [20]. In the absence of
chest pain and ECG abnormalities, all tests were contin-
ued as symptom-limited (volitional exertion, dyspnoea
or fatigue). Prior to the test, patients were encouraged to
reach maximal exhaustion, while during exercise no fur-
ther motivational interventions were made. All tests
were performed at room air according to current guide-
lines for exercise testing, with continuous monitoring of
ECG, blood pressure and oxygen saturation [21,22].
Peak oxygen uptake (peakVO2) was defined as the highest
10-second average of VO2 in the last minute of exercise.
The oxygen uptake at anaerobic threshold (VO2@AT) was
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mination of anaerobic threshold (AT) was based on three
methods: non-invasive determination by gas exchange ana-
lysis by investigating the relation of VO2 to VCO2 (V-slope
method), end-tidal gas concentrations over time and venti-
latory equivalents for oxygen and carbon dioxide over time
[23]. At least two of the three methods had to be compliant.
Maximal power output was characterised as the highest
reached power in Watts (W) which was maintained for at
least 20 seconds on the bicycle ergometer during exercise.
All investigated parameters have been shown to be reliably
reproducible [24]. Exercise duration was investigated as
from the start of exercise (without resting period) up to its
termination.
In the present study CPET was performed up to
100 days after core investigation (blood sampling). The
median time-lag was 28 days (25th percentile 9 days; 75th
percentile 48 days). All analyses were also performed in
a subpopulation of 402 subjects with a maximal time-lag
of one month [median 11 days (25th percentile 3 days;
75th percentile 21 days)].
Statistical analysis
Continuous data are expressed as median (25th percent-
ile; 75th percentile). Nominal data are expressed as per-
centages. For bivariate analyses the Kruskal-Wallis test
(continuous data) or χ2-test (nominal data) were used to
compare men and women, as well as participants and
non-participants. Analysis of variance (ANOVA) was
carried out to calculate adjusted means for CPET pa-
rameters in groups (categorisation according to sex- and
months-specific tertiles). Multivariable linear regression
models were separately performed in men and women
to estimate the independent associations of irisin as a
continuous variable with CPET parameters. To detect
possible nonlinear associations, for both analyses models
with restricted cubic splines with 3 knots pre-specified
located at the 5th, 50th, and 95th percentile as recom-
mended by Stone and Koo [25] were compared by a like-
lihood ratio test to the fit of the linear model. The full
models were adjusted for age, body-mass index, smok-
ing, time between core examination and CPET and
months of core examination. Furthermore, in linear re-
gression analyses glucose and total cholesterol levels
were tested as further potential confounders. Sensitivity
analyses were performed with either the exclusion of 1)
all subjects with chronic obstructive pulmonary disease
(COPD), defined as FEV1/FVC <0.7 or intake of drugs
for obstructive airway diseases (ATC code R03), or 2) all
subjects with a time-lag between blood sampling and
CPET of more than one month. A value of p < 0.05
was considered statistically significant. Statistical ana-
lyses were performed with SAS 9.3 (SAS Institute
Inc., Cary, NC, USA).Results
Men and women were compared according to general
characteristics (Table 1). Women were more often never
smokers and had a lower WC and body-mass index than
men. Furthermore, women were less often affected by
hypertension and had lower blood glucose but higher
total cholesterol levels when compared to men. With
respect to CPET parameters, men had higher levels of
peakVO2, VO2@AT, oxygen pulse and a higher power
output at peak exercise than women. Regarding irisin
no overall sex differences were apparent. However, our
data showed a strong annual rhythm of irisin levels. As
displayed in Figure 1, irisin showed peak values in the
winter (December – February) and summer months
(July – August) compared to the remaining months.
Even if men and women showed similar rhythms,
women exhibited significant higher irisin levels in se-
lected months. Compared to non-participants, the par-
ticipants were more often women, never smokers, more
physically active, had a lower body-mass index and glu-
cose levels and were less often affected by hypertension.
In the whole population, ANOVA (Figure 2) revealed
trends towards inverse associations between categories
of irisin and peakVO2 as well as maximum power out-
put among men. The estimated mean level of peakVO2
or maximum power output was 138 ml/min or 11
watts higher in the first [peakVO2 (ml/min): 2656
(95% confidence interval (CI) 2566, 2747); maximum
power output (watt): 207 (95%-CI 200, 214)] compared
to the third tertile [peakVO2: 2518 (95%-CI 2428,
2518); maximum power output: 196 (95%-CI 189,
202)], respectively. The associations became weaker
after the exclusion of men with a time-lag between
blood sampling and CPET of more than one month
(Figure 2). However, still higher estimated mean levels
of peakVO2 [1
st tertile: 2639 (95%-CI 2527, 2752); 3rd
tertile: 2508 (95%-CI 2359, 2656)] or maximum power
output [1st tertile: 207 (95%-CI 199, 216); 3rd tertile:
193 (95%-CI 183, 205)] could be observed in the first
compared to the third irisin tertile. In the subgroup of
women with a maximal time-lag of one month, cat-
egorical analyses suggest a positive association be-
tween irisin tertiles and oxygen pulse [1st tertile: 10.5
(95%-CI 10.0, 11.0); 3rd tertile: 11.3 (95%-CI 10.8,
11.7)]. No association between irisin and VO2@AT or
oxygen pulse was found in either sex.
Fully adjusted linear regression analyses confirmed the
inverse association between irisin and peakVO2 as well
as maximum power output (Figure 3 and Table 2) and
additionally revealed an inverse relationship with oxygen
pulse in men. These findings were independent of the
study population used. Furthermore, among women, after
excluding those with a large time-lag between blood sam-
pling and CPET, significant positive associations between




Complete (N = 740) p† Men (N = 322) Women (N= 418) p‡
Age (years)* 53 (39.5; 65) 51 (41; 61) <0.01 50 (39; 61) 52 (41; 61) 0.54
Men (%) 49.2 45.1 0.04 - -
Smoking (%) <0.01 <0.01
never smokers 35.3 42.4 32.0 51.0
former smokers 36.4 37.8 48.5 29.1
current smokers 28.4 19.7 19.5 19.9
Physical activity (%) 67.9 75.0 <0.01 73.9 75.8 0.55
Waist circumference (cm) 91.4 (80.9; 102.0) 87.1 (78.5; 97.0) <0.01 94.0 (86.5; 102.5) 81.1 (74.0; 90.0) <0.01
Body-mass-index (kg/m2) 27.7 (24.5; 31.3) 26.8 (24.1; 30.0) <0.01 27.8 (25.0; 30.3) 26.1 (23.2; 29.5) <0.01
Glucose (mmol/l) 5.4 (5.0; 6.0) 5.3 (4.9; 5.7) <0.01 5.4 (5.1; 5.9) 5.2 (4.9; 5.6) <0.01
Total cholesterol (mmol/l) 5.4 (4.6; 6.1) 5.4 (4.7; 6.2) 0.11 5.3 (4.6; 6.1) 5.5 (4.9; 6.2) 0.02
Hypertension (%) 50.1 38.7 <0.01 43.1 35.1 0.03
Irisin (μg/ml) - - - 1.97 (1.47; 2.70) 2.01 (1.48; 2.71) 0.69
peak VO2 (ml/min) - - - 2600 (2183; 3000) 1611 (1400; 1925) <0.01
VO2@AT (ml/min) - - - 1200 (1000; 1400) 850 (800; 1000) <0.01
Oxygen pulse (ml) - - - 16.1 (14.4; 18.1) 10.9 (9.3; 12.2) <0.01
Maximum power output (watt) - - - 196 (180; 228) 132 (116; 148) <0.01
Peak VO2 = highest 10-second average of VO2 in the last minute of exercise; VO2@AT = VO2 at lactate threshold. Continuous data are expressed as median (25
th
and 75th percentiles; nominal data are given as percentages. χ2-test (nominal data) or Kruskal-Wallis test (interval data) were used to compare non-participants
with participants (†) or participating men and women (‡). *Age at core examination.
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became apparent in a fully adjusted model. No further
significant associations were found in women. The add-
itional adjustment for self-reported physical activity did
not change the detected findings (Additional file 1: Table
S1). The exclusion of subjects with COPD also confirmed
the reported findings of the linear regression analyses even
though some of the relationships were short of being sta-
tistically significant (Additional file 1: Table S2). One rea-
son for the weaker associations might be the loss of
power.Figure 1 Boxplots of irisin levels separately for men (blue) and women (reDiscussion
In the present study inverse associations between irisin
and exercise capacity assessed by peakVO2, oxygen pulse
and maximum power output were found among men.
Furthermore, in a subgroup of women with a time-lag
between blood sampling and CPET of less than one
month, however, positive relationships between irisin
and peakVO2 as well as oxygen pulse were detected.
Irisin is a recently discovered PGC1α dependent myo-
kine. Originally PGC1α has been described as a co-
activator of biological mechanisms linked with energyd) by month. * p < 0.05 for comparison between men and women.
Figure 2 Estimated mean level of highest 10-second average of VO2 in the last minute of exercise (peak VO2), VO2 at lactate threshold (V02@AT),
maximum power output and oxygen pulse with 95% confidence interval by sex- and month-specific tertiles of irisin. Analysis of variance was
adjusted for age, body-mass index, smoking and time between core examination and pulmonary function testing. *The whole population as well
as only subjects with a maximal time-lag between blood sampling and pulmonary function testing of one month.
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tive association between irisin and peakVO2 in women,
Boström and colleagues [4] reported an exercise-related in-
crease in expression of FNDC5 and consequently increased
irisin levels in mice after three weeks of free wheel running.
The authors also confirmed their findings among eight
healthy but obese participants by showing a significant in-
crease in irisin levels after 10 weeks of endurance training.
However, the study population was rather small to drawn
conclusions from these results. Recently published studies
[12,13,26] further revealed an acute increase in irisin levels
after 30 min, 45 min or 54 min of endurance exercise.
However, after 90 min or 8 weeks of training irisin levels
were no longer elevated [13] and even more interesting,
after 12 weeks of training a decrease in irisin levels was ob-
served in 13 healthy and 13 pre-diabetic participants [12].
The long-term reduction in irisin levels is in concordance
with present detected inverse relationships between irisin
and peakVO2 or maximum power output among men.
However, these studies are contradicted by a study [27]
among 163 Japanese men also using cardiopulmonary exer-
cise parameters which did not revealed any correlation
between peak VO2 and irisin levels. Reasons for thedifferent findings might be the different sample size as well
as different methods used to measure irisin levels.
In general, there is a broad range of studies [15-17]
that indicate no relationship between exercise and irisin
levels. An investigation among 102 participants who
took part in either a strength or aerobic endurance
training program for 26 weeks did not show any
exercise-induced increase in irisin levels [17]. Further
studies conducted among healthy [15,16] and obese sub-
jects [14] as well as among haemodialysis patients [15]
and patients with anorexia nervosa [28], also showed no
significant alterations in irisin levels after aerobic exer-
cise, resistance exercise or/and endurance exercise. The
majority of these studies were conducted in experimen-
tal settings and included less than 100 subjects, therefore
the present results based on over 700 subjects might fur-
ther contribute to the ongoing discussion of the physio-
logical and pathophysiological actions of irisin.
Most of the studies analysed both men and women at
the same time, which might be a further reason for the in-
consistent results. One previous study [29], also per-
formed sex-specific analyses and firstly revealed a sexual
dimorphic response to circulating irisin levels. Whereas in
Figure 3 Predicted mean of highest 10-second average of VO2 in the last minute of exercise (peak VO2), VO2 at lactate threshold (V02@AT), maximum
power output and oxygen pulse depending on irisin levels calculated by linear regression analyses for men (blue) and women (red). Models were
adjusted for 1) age, body-mass index, smoking, glucose, total cholesterol levels as well as time between core examination and pulmonary function
testing and months of core examination. *The whole population (solid lines) as well as only subjects with a maximal time-lag between blood sampling
and pulmonary function testing of one month (dashed lines).
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ing irisin levels was found, a positive association became
apparent among women. These findings support our re-
sults regarding exercise parameters in men and women.
The authors suggest differences in transcription levels of
FNDC5, body composition or sexual hormones as possible
explanations [29]. However, in the present study popula-
tion, no correlation between irisin levels and either an-
thropometric marker, including body-mass index or
visceral and subcutaneous fat measured based on MRI, or
sexual hormones including total testosterone, androstene-
dione or estradiol became apparent. Therefore, further
studies are needed to elucidate the mechanism underlying
the sex differences regarding the relationship between iri-
sin levels and exercise capacity.
The majority of the above-mentioned studies exam-
ined the direct association between various types of ex-
ercise and irisin levels. One possible reason for the
discrepancies between the previous studies and ours
might be that the present study represents a cross-sectional investigation of the association between phys-
ical performance measured by cardiopulmonary exercise
testing and irisin levels and is therefore more likely to
reflect the physical and training status when the exercise
test was performed. Our study did not investigate the ef-
fects of exercise itself on irisin levels. Furthermore, the
conflicting findings might be caused by different study
settings which lead to different distributions of con-
founding factors such as age, body composition,
cholesterol levels or fitness status. A recent study [26]
has dealt with these confounding factors and clearly
demonstrated that irisin levels were positively corre-
lated with biceps circumference (as a marker of muscle
mass herein), body-mass index, glucose ghrelin and
insulin-like growth factor I levels and, on the other
side, negatively correlated with age, insulin, cholesterol
and adiponectin levels. In general, besides several influ-
encing factors causing fluctuations in irisin levels, the
origin of irisin is still not fully understood. A previous
study [30] found that irisin is not only a myokine but
Table 2 Association between irisin and CPET parameters depending on different adjustment sets











Men (n = 322)
adjusted for age, BMI, smoking −97.43 (43.139) 0.02 −6.388 (26.278) 0.81 −0.463 (0.249) 0.06 −7.656 (3.258) 0.02
adjusted for age, BMI, smoking,
glucose, total cholesterol
−108.2 (43.752) 0.01 −11.48 (26.618) 0.67 −0.544 (0.252) 0.03 −8.434 (3.305) 0.01
Women (n = 418)
adjusted for age, BMI, smoking 27.580 (23.166) 0.23 0.981 (13.347) 0.94 0.054 (0.149) 0.72 −1.296 (1.872) 0.49
adjusted for age, BMI, smoking,
glucose, total cholesterol
25.103 (23.337) 0.28 −0.805 (13.436) 0.95 0.021 (0.150) 0.89 −1.410 (1.887) 0.46
Subpopulation of subjects with a maximal time-lag between blood sampling and pulmonary function testing of one month
Men (n = 177)
adjusted for age, BMI, smoking −96.07 (58.396) 0.10 4.926 (35.355) 0.89 −0.442 (0.335) 0.19 −8.720 (4.413) 0.05
adjusted for age, BMI, smoking,
glucose, total cholesterol
−116.9 (60.121) 0.05 2.569 (36.563) 0.94 −0.557 (0.342) 0.11 −9.979 (4.557) 0.03
Women (n = 225)
adjusted for age, BMI, smoking 80.507 (27.836) <.01 24.328 (18.694) 0.19 0.455 (0.177) 0.01 1.839 (2.302) 0.43
adjusted for age, BMI, smoking,
glucose, total cholesterol
80.805 (28.106) <.01 22.367 (18.856) 0.24 0.446 (0.179) 0.01 1.775 (2.326) 0.45
BMI = body-mass index; peakVO2 = highest 10-second average of VO2 in the last minute of exercise; VO2@AT = VO2 at anaerobic threshold. All models were further
adjusted for time between core examination and pulmonary function testing and month of core examination.
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sin in a great variety of tissues ranging from pericar-
dium, rectum and heart to kidney, liver, lung and
adipose tissue. Thus it is very questionable if irisin is
actually mainly secreted by muscle tissue or just acci-
dently secreted in this tissue in response to exercise.
Therefore, further investigations are needed to clarify
the potential physiological association between irisin
and exercise as well as obesity.
Additionally, we came across something unexpected
and new in the history of irisin: an annual rhythm of
irisin levels. According to the collected data irisin levels
show two peaks, one during the summer and the other
during the winter period. A possible explanation might
be a variation in physical activity during the year. In
summer months, people are more likely to be active
outside, to do sports and to walk around. This might
lead to an exercise-related increase in irisin levels. Dur-
ing the winter period, to compensate for lower outside
temperature the overall exercise rate might be higher
related to the rise in energy expenditure and shivering-
linked thermogenesis. Another speculative reason might
be the higher percentage of adipose tissue present during
the winter months. Currently irisin has been found to be
an adipokine which is secreted by white adipose tissue
and especially by subcutaneous adipose tissue [30].A further reason might be heterogeneity between sub-
jects examined in different months. Even if we found no
significance differences for general characteristics e.g.
age, smoking, body-mass index, glucose levels or propor-
tion of hypertension (data not shown) between subjects
examined in different months, further studies are needed
to clarify the detected annual rhythm of irisin levels.
The strengths of the present study are the large
population of over 700 participants and the accurate
assessment of confounding factors and exercise param-
eters based on standardised protocols. Furthermore, we
firstly investigated the possible sex-specific difference
in the association between exercise and irisin levels in a
large-scale population sample. However, there are also
limitations. With respect to the interpretation of the re-
sults, there might be a problem regarding linking the
oxygen uptake directly to the exercise taken. We as-
sume that our method to assess physical capacity might
have a large influence on the results. Furthermore, fac-
tors like menopause status which might influence the
muscle status of women were not considered due to
the lack of reliable data.
Conclusion
In conclusion, we detected inverse associations between
irisin and exercise capacity assessed by peakVO2 and
Kerstholt et al. BMC Pulmonary Medicine  (2015) 15:41 Page 8 of 9maximum power output among men and a trend toward
a positive relationship between irisin and peakVO2
among women, suggesting possible sex differences.
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